The Asia Pacific Laboratory Robotics Market would witness market growth of 7.5% CAGR during the forecast period (2024-2031).
The China market dominated the Asia Pacific Laboratory Robotics Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $177.6 million by 2031. The Japan market is capturing a CAGR of 7% during (2024 - 2031). Additionally, The India market would register a CAGR of 8.4% during (2024 - 2031).
In industrial laboratories, robots perform automated inspections, sample testing, and product validation. This ensures product quality, compliance with regulatory standards, and consistency in manufacturing processes. Automated systems analyze water, air, and soil samples for contaminants, pollutants, and microbial pathogens. This supports environmental monitoring, regulatory compliance, and public health assessments.
The adoption of laboratory robotics has been steadily increasing across various industries and scientific disciplines, driven by technological advancements, efficiency gains, and the need for high precision and throughput. Laboratory robotics have evolved significantly, integrating advanced technologies such as AI, machine learning, and robotic vision systems. These advancements enhance robotic capabilities in handling complex tasks, adapting to variable conditions, and improving overall system performance. Robotic platforms offer greater flexibility, scalability, and integration with other laboratory instruments and systems, making them more attractive for adoption in diverse applications.
China’s pharmaceutical sector increasingly adopts laboratory robotics for automated drug discovery processes, including high-throughput screening (HTS) and compound management. Robotics enable pharmaceutical companies to efficiently handle large-scale screening of drug candidates, accelerating the discovery of new therapies while reducing labour costs and improving accuracy. According to the International Trade Administration (ITA), China’s pharmaceutical sector has constantly grown and reached $161.8 billion in 2023, taking about 30% of the global industry share. Laboratory robotics are crucial in biomanufacturing facilities across China, automating cell culture, fermentation, and purification processes. Robotics ensure consistent product quality, scalability, and operational efficiency in biopharmaceutical production, meeting the growing demand for innovative therapies and biologics.
The adoption of laboratory robotics in China supports advancements in precision medicine and personalized healthcare solutions. Robotics enable precise handling of biological samples, genomic sequencing, and biomarker analysis, facilitating tailored treatment approaches and enhancing patient outcomes through targeted therapies. The burgeoning biotechnology sector and expanding regional pharmaceutical industry are key drivers propelling market growth.
Free Valuable Insights: The Global Laboratory Robotics Market is Predict to reach USD 2.6 Billion by 2031, at a CAGR of 6.9%
Based on End Use, the market is segmented into Clinical Laboratory and Research Laboratory. Based on Application, the market is segmented into Drug Discovery, Genomics Solutions, Clinical Diagnosis, Proteomics Solutions, and Microbiology Solutions. Based on Product, the market is segmented into Lab Automation Workstations, Automated Plate Handlers, Automated Liquid Handling Robots, Robotic Arms, Microplate Readers and Washers, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.
By End Use
By Application
By Product
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 